Home > Boards > US Listed > Biotechs > Bio-Path Holdings Inc. (BPTH)

BPTH running again.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
SJSTOCKSHARK Member Profile
 
Followed By 11
Posts 1,595
Boards Moderated 1
Alias Born 09/19/06
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/2/2019 4:06:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/2/2019 10:22:49 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/27/2019 4:38:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/26/2019 4:32:06 PM
Bio-Path Holdings Announces Successful Completion of Safety Testing in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leu... GlobeNewswire Inc. - 11/26/2019 8:00:10 AM
Bio-Path Holdings Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/25/2019 2:11:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/22/2019 5:26:35 PM
Bio-Path Holdings Announces $8.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/21/2019 11:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/21/2019 8:21:07 AM
Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 GlobeNewswire Inc. - 11/21/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2019 7:08:27 AM
Bio-Path Holdings Reports Third Quarter 2019 Financial Results GlobeNewswire Inc. - 11/15/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:25:09 PM
Bio-Path Holdings to Announce Third Quarter 2019 Financial Results on November 15, 2019 GlobeNewswire Inc. - 11/8/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/1/2019 4:49:22 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/1/2019 4:46:18 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/22/2019 5:06:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 4:24:51 PM
Bio-Path Holdings Appoints Martina Molsbergen to Board of Directors GlobeNewswire Inc. - 10/15/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2019 5:17:26 PM
Bio-Path Updates Intellectual Property Portfolio with Addition of Recently Issued Second Platform Technology Patent GlobeNewswire Inc. - 9/25/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 4:07:11 PM
Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 9/3/2019 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2019 6:02:06 AM
Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia GlobeNewswire Inc. - 8/26/2019 7:00:00 AM
SJSTOCKSHARK   Monday, 10/14/19 12:25:31 PM
Re: None
Post # of 6229 
BPTH running again.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist